Back to companies

Fulcrum Therapeutics Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Fulcrum Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Fulcrum Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Kate Haviland

Chairman Executive Board Since: 2022 Age: 50

Alex C. Sapir

Director; Chief Executive Officer; President Executive Board Since: 2023 Age: 59

Alan Musso

Chief Financial Officer Senior Management Since: 2023 Age: 64

Curtis Oltmans

Chief Legal Officer; Head - External Affairs Senior Management Since: 2025 Age: 62

Bobby Riehle, Ph.D.

Head - Program Strategy; Vice President Senior Management Since: 2025
Gain a 360-degree view of Fulcrum Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Fulcrum Therapeutics Inc and make more informed decisions for your business Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer